Literature DB >> 9344409

A continuous colorimetric assay for rhinovirus-14 3C protease using peptide p-nitroanilides as substrates.

Q M Wang1, R B Johnson, G A Cox, E C Villarreal, R J Loncharich.   

Abstract

Human rhinovirus encoded 3C protease is an attractive target for antiviral drug development. However, lack of a convenient and selective assay for 3C protease has been a hindrance in characterization of this enzyme and evaluation of a large number of potential inhibitors. In the present study we describe development of a simple, continuous colorimetric assay for this enzyme using peptide p-nitroanilides (pNA) as substrates. Several peptides mimicking the native 3C cleavage site of HRV-14 polyprotein have been synthesized with an N-acylated p-nitroaniline at position P1' and examined as substrates for the purified 3C protease. In these peptides, amino acids downstream from the original cleavage site have all been replaced with a chromophoric p-nitroaniline moiety which is directly linked to the bond undergoing enzymatic cleavage, thereby generating a new cleavage site Gln-pNA for the enzyme. Hydrolysis of these pNA peptides by 3C at the newly formed scissile bond releases free p-nitroaniline which is yellow-colored and can be continuously monitored at a visible wavelength. Kinetic parameters of 3C protease toward these peptides have been measured and analyzed. In addition, the pNA peptides have been modeled within the active site of the 3C protease to investigate the ability of the pNA group to act as a replacement for Gly-Pro in the prime side. The selectivity and applicability of this assay and its advantages over the previously described methods have been demonstrated and discussed. Since multiple tests can be performed simultaneously in one microtiter plate, the assay is ideal for evaluation of a large number of samples. Copyright 1997 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9344409     DOI: 10.1006/abio.1997.2315

Source DB:  PubMed          Journal:  Anal Biochem        ISSN: 0003-2697            Impact factor:   3.365


  10 in total

1.  Dual inhibition of human rhinovirus 2A and 3C proteases by homophthalimides.

Authors:  Q M Wang; R B Johnson; L N Jungheim; J D Cohen; E C Villarreal
Journal:  Antimicrob Agents Chemother       Date:  1998-04       Impact factor: 5.191

2.  Enzymatic characterization of refolded human rhinovirus type 14 2A protease expressed in Escherichia coli.

Authors:  Q M Wang; R B Johnson; G A Cox; E C Villarreal; L M Churgay; J E Hale
Journal:  J Virol       Date:  1998-02       Impact factor: 5.103

3.  Backbone 1H, 15N and 13C assignments for the human rhinovirus 3C protease (serotype 14).

Authors:  Trent C Bjorndahl; Hassan Monzavi; David S Wishart
Journal:  J Biomol NMR       Date:  2003-05       Impact factor: 2.835

4.  Hepatitis A virus proteinase 3C binding to viral RNA: correlation with substrate binding and enzyme dimerization.

Authors:  Hannelore Peters; Yuri Y Kusov; Sonja Meyer; Andrew J Benie; Englbert Bäuml; Maike Wolff; Christoph Rademacher; Thomas Peters; Verena Gauss-Müller
Journal:  Biochem J       Date:  2005-01-15       Impact factor: 3.857

5.  Structure of Mpro from SARS-CoV-2 and discovery of its inhibitors.

Authors:  Zhenming Jin; Xiaoyu Du; Yechun Xu; Yongqiang Deng; Meiqin Liu; Yao Zhao; Bing Zhang; Xiaofeng Li; Leike Zhang; Chao Peng; Yinkai Duan; Jing Yu; Lin Wang; Kailin Yang; Fengjiang Liu; Rendi Jiang; Xinglou Yang; Tian You; Xiaoce Liu; Xiuna Yang; Fang Bai; Hong Liu; Xiang Liu; Luke W Guddat; Wenqing Xu; Gengfu Xiao; Chengfeng Qin; Zhengli Shi; Hualiang Jiang; Zihe Rao; Haitao Yang
Journal:  Nature       Date:  2020-04-09       Impact factor: 49.962

Review 6.  An overview of enzymatic reagents for the removal of affinity tags.

Authors:  David S Waugh
Journal:  Protein Expr Purif       Date:  2011-08-19       Impact factor: 1.650

7.  High-throughput protein production and purification at the Seattle Structural Genomics Center for Infectious Disease.

Authors:  Cassie M Bryan; Janhavi Bhandari; Alberto J Napuli; David J Leibly; Ryan Choi; Angela Kelley; Wesley C Van Voorhis; Thomas E Edwards; Lance J Stewart
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2011-08-13

8.  Antiviral activities of peptide-based covalent inhibitors of the Enterovirus 71 3C protease.

Authors:  Yong Wah Tan; Melgious Jin Yan Ang; Qiu Ying Lau; Anders Poulsen; Fui Mee Ng; Siew Wen Then; Jianhe Peng; Jeffrey Hill; Wan Jin Hong; Cheng San Brian Chia; Justin Jang Hann Chu
Journal:  Sci Rep       Date:  2016-09-20       Impact factor: 4.379

9.  High Throughput Virtual Screening to Discover Inhibitors of the Main Protease of the Coronavirus SARS-CoV-2.

Authors:  Olujide O Olubiyi; Maryam Olagunju; Monika Keutmann; Jennifer Loschwitz; Birgit Strodel
Journal:  Molecules       Date:  2020-07-13       Impact factor: 4.411

10.  Production of authentic SARS-CoV M(pro) with enhanced activity: application as a novel tag-cleavage endopeptidase for protein overproduction.

Authors:  Xiaoyu Xue; Haitao Yang; Wei Shen; Qi Zhao; Jun Li; Kailin Yang; Cheng Chen; Yinghua Jin; Mark Bartlam; Zihe Rao
Journal:  J Mol Biol       Date:  2006-12-01       Impact factor: 5.469

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.